Evidera White Paper Highlights PPI in Europe

A recent white paper by Evidera, “Patient Preferences in Health Technology Assessment in Europe: Recent Advances and Future Potential,” spotlights the use of patient preference information (PPI) in Europe, and what could be in store for the future.

“PPI is increasingly used to support regulatory decisions, and sponsors and HTA agencies are actively exploring how this data can also support reimbursement decisions,” the article states. “A small number of HTA agencies have specified the use of PPI in their methods guidance, but most agency use of PPI is less systematic, either being in the form of novel examples of the use of PPI or at a pilot stage.”

To read more on Evidera’s site, click here.